Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Zheng, Xiao"'
Publikováno v:
Seizure. 91:34-39
Purpose Stigma toward people with epilepsy (PWE) is common around the globe. Perceived stigma produced by mental or physical disorders may represent a significant risk factor for suicide.This study examines whether and how perceived stigma, unemploym
Publikováno v:
Investigational New Drugs. 39:627-635
Arborinine is a natural product isolated from G. parva leaf extracts, which displays potentially antiproliferative activity against human cervical cancer cells. In contrast, its anticancer effects against gastric cancer cells and drug-resistant gastr
Autor:
Ding Yan-rui, Sun Ying, Cheng Shu, Li Bin, Liang Jing, Qin Fanggang, Bai Yajun, Chen Xufei, Zheng Xiao-hui, Bai Yujun, Xie Jing
Publikováno v:
Letters in Drug Design & Discovery. 17:891-904
Background: Our previous studies showed that α-asaronol was a potential antiepileptic candidate. Here, twelve O-terminus modified ester derivatives of α-asaronol were designed, synthesized and evaluated their anticonvulsant activity. Methods: All s
Publikováno v:
Biochemical and Biophysical Research Communications. 520:79-85
Prolactinoma is a clinically common intracranial tumor. When serum prolactin levels are not controlled despite administration of a dopamine agonist, the condition is referred to as drug-resistant prolactinoma. The mechanism underlying persistent prol
Autor:
Zheng Xiao, Qiu Du, Xin Wang, Yonghong Zhu, Diming Zhu, Dongsheng He, Zhigang Mao, Xiangsong Zhang, Haijun Wang, Zongming Wang
Publikováno v:
Academic Radiology. 26:1222-1228
RATIONALE AND OBJECTIVES It is clinically essential, but sometimes challenging, to distinguish pituitary tissue from pituitary adenomas (PAs). It is helpful to avoid damage of pituitary tissue during management. We evaluated the ability of 13N-ammoni
Autor:
Cheng-Qiong Wang, Xiao-Rong Huang, Min He, Xiao-Tian Zheng, Hong Jiang, Qian Chen, Teng-Yan Fan, Lin Zhan, Juan Ling, Ji-Hong Feng, Xue Xiao, Xiao-Fan Chen, Zheng Xiao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
IntroductionA modified and recombinant human endostatin (Rh-endostatin) is often used in the control of malignant pleural effusion (MPE) through intrapleural infusion.ObjectivesTo demonstrate the clinical response, survival, and safety of Rh-endostat
Autor:
Xiaowu Liu, Xue Hu, Chunyin Gu, Zhiming Yuan, Xin Chen, Li Yu, Wuxiang Guan, Li Gao, Nan Li, Zhongzong Pan, Tianquan Hou, Su Jun Deng, Hong Liang, Congyi Yang, Xueyi Huang, Meng Shi, Fangfang Jia, Lu Yang, Yun Peng, Ge Gao, Kunpeng Liu, Donglin Song, Weiwei Guo, Zhen Chen, Chao Shan, Haixia Ma, Guoping Jiang, Yiwu Zhou, Zongda Wang, Xueping Wang, Jianjian Zhang, Yanan Li, Peipei Liu, Zheng Xiao, Yecheng Zhang, Juan Min, Guoqiao Lu, Xiaodan Cao, Yuting Wang, Yanfeng Yao, Weichen Liang, Kaiwen Xia, Jianhua Xue, Haibing Guo, Xiao Hu
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease-2019 (COVID-19), interacts with the host cell receptor angiotensin-converting enzyme 2 (hACE2) via its spike 1 protein during infection. After the virus se
Autor:
Cheng-Qiong Wang, Xiao-Tian Zheng, Xiao-Fan Chen, Hong Jiang, Jun Huang, Yuan Jiang, Shan-Shan Hu, Xiao-Rong Huang, Shi-Yu Liu, Qi-Hai Gong, Ji-Hong Feng, Xue Xiao, Xiao-Fei Li, Zheng Xiao
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Aidi injection (Aidi) is composed of cantharidin, astragaloside, ginsenoside, and elentheroside E. As an important adjuvant therapy, Aidi in combination with gemcitabine and cisplatin (GP) is often used in the treatment of non-small cel
Autor:
Jia-hui Zhang, Hongcai Shang, Xing-qian Yi, Wei-Feng Zhu, Heyun Nie, Xiao-Fan Chen, Xu Zhou, Xin Sun, Xin-yu Yu, Zheng Xiao, Qian Chen, Qing-ying He, Shu-xian Chen
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Objectives: Danhong injections (DHI) are widely used in the treatment of acute myocardial infarction (AMI). As there are no guidelines for the timing of DHI in the peri-percutaneous coronary intervention (PCI) period for AMI, we investigated the effe
Publikováno v:
Medicine
Background: Concurrent chemoradiotherapy is widely utilised as a standardized primary method of treatment for patients with advanced nasopharyngeal carcinoma (NPC). However, the combination of concurrent chemoradiotherapy and adjuvant chemotherapy fo